Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 1/2016

01-01-2016 | Endocrine Imaging

Thyroid carcinoma detected by incidental 18F-FDG uptake in a patient with progressive cerebellar syndrome

Authors: Alexander Kroiss, Christian Uprimny, Irene Johanna Virgolini

Published in: Endocrine | Issue 1/2016

Login to get access

Excerpt

Thyroid incidentalomas are defined as unexpected, asymptomatic thyroid lesions that are discovered on an imaging study or during surgery unrelated to the thyroid gland. Most of thyroid incidentalomas are benign, though carrying a significant risk of malignancy in about 2 % [1]. …
Literature
1.
G. Treglia, F. Bertagna, R. Sadeghi, F.A. Verburg, L. Ceriani, L. Giovanella, Focal thyroid incidental uptake detected by 18F-fluorodeoxyglucose positron emission tomography. Nuklearmedizin 52, 130–136 (2013)PubMedCrossRef
2.
M. Salvatori, L. Melis, P. Castaldi et al., Clinical significance of focal and diffuse thyroid diseases identified by 18F-fluorodeoxyglucose positron emission tomography. Biomed. Pharmacother. 61, 488–493 (2007)PubMedCrossRef
3.
L. Bataller, J. Dalmau, Paraneoplastic neurologic syndromes: approaches to diagnosis and treatment. Semin. Neurol. 23, 215–224 (2003)PubMedCrossRef
Metadata
Title
Thyroid carcinoma detected by incidental 18F-FDG uptake in a patient with progressive cerebellar syndrome
Authors
Alexander Kroiss
Christian Uprimny
Irene Johanna Virgolini
Publication date
01-01-2016
Publisher
Springer US
Published in
Endocrine / Issue 1/2016
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-015-0646-2

Other articles of this Issue 1/2016

Endocrine 1/2016 Go to the issue

Original Article

Relation of thyroid hormone abnormalities with subclinical inflammatory activity in patients with type 1 and type 2 diabetes mellitus

Original Article

γδ Τ cells enhance B cells for antibody production in Hashimoto’s thyroiditis, and retinoic acid induces apoptosis of the γδ Τ cell

Original Article

Subsequent mortality after hyperglycemic crisis episode in the non-elderly: a national population-based cohort study

Original Article

Minimally invasive follicular carcinoma: predictors of vascular invasion and impact on patterns of care

Original Article

The cAMP analogs have potent anti-proliferative effects on medullary thyroid cancer cell lines

Original Article

Testosterone stimulates glucose uptake and GLUT4 translocation through LKB1/AMPK signaling in 3T3-L1 adipocytes
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits